Featured Research

from universities, journals, and other organizations

Medical Researchers Say Statins, Other Cholesterol-Depleting Agents Affect Hypertension

Date:
April 12, 2005
Source:
University Of California, San Diego
Summary:
Cholesterol-lowering agents, such as the widely-prescribed statin drugs, and cholesterol-blocking agents may prove to be “novel therapeutic agents to modify cellular calcium that contributes to the development of pulmonary hypertension,” according to Hemal H. Patel, who leads a multidisciplinary team of researchers at the UCSD School of Medicine.

Cholesterol-lowering agents, such as the widely-prescribed statin drugs, and cholesterol-blocking agents may prove to be “novel therapeutic agents to modify cellular calcium that contributes to the development of pulmonary hypertension,” according to Hemal H. Patel, who leads a multidisciplinary team of researchers at the UCSD School of Medicine.

Presenting his research at the 35th Congress of the International Union of Physiological Sciences on Tuesday, April 5 in San Diego, Patel said the team found a previously unappreciated cellular and molecular mechanism for the disease process in idiopathic pulmonary hypertension (IPAH), which was previously called primary pulmonary hypertension. He added that the mechanism found may be amenable to treatment with current and future therapies and might provide more substantial, long-term and efficacious benefit to those who have IPAH.

A severe clinical disease with a poor prognosis, untreated IPHA leads to heart failure and death in two to eight years. Because of limited understanding of the cellular and molecular determinants of the disease process, current therapy is limited and aimed towards symptomatic relief.

Patel, who is a post doctoral fellow in the lab of Paul Insel, M.D., UCSD professor of pharmacology, said two factors that contribute to the disease are dependent on cellular calcium: constriction of vessels, and uncontrolled cell growth resulting in thickening of vessels. The UCSD team sought to determine if IPAH has altered caveolae, which in Latin means “little caves,” on the membrane composed of cholesterol that control the intake of calcium into cells. They also wanted to know if agents that modify cellular cholesterol might limit calcium intake and ultimately limit the two factors (constriction and growth) in vessels that contribute to the disease process. These drugs then might provide for a novel therapy that not merely provides temporary relief of disease symptoms, but helps alleviate the underlying cause of IPAH.

In their research, the team saw that “smooth muscle cells isolated from pulmonary arteries of patients with IPAH indeed had more caveolae on the cell membrane compared to cells from normal individuals, and also that there was a higher calcium intake into the diseased cells,” Patel reported. Subsequent treatment of the IPAH cells with an agent that depletes cholesterol (methyl-beta-cyclodextrin, or MBCD), or “a statin (in this case, lovostatin, sold as Mevacor by Merck), which blocks cholesterol synthesis, resulted in a disruption of the caveolae and reduced the amount of calcium that entered the cells.

“Additionally, these two treatments also decreased the growth rate of the diseased cells,” Patel said. Taken together, the results “mean that the micro-structure of the cell membrane is involved in controlling the intake of calcium and that the cholesterol modifiers of these structures may serve as novel therapeutics to reduce vessel constriction and cell growth associated with increased calcium intake in IPAH,” Patel stated.

The next steps, Patel explained, are to understand the nature of the proteins located on the caveolae and how these structures communicate with the internal regions of cells to influence calcium intake into the cell. He said the UCSD researchers “already have begun looking at the expression and localization of ion channels into caveolae that may further explain the increased calcium intake into cell.”

In addition to Patel, researchers included Insel and Fiona Murray, Ph.D., UCSD Department of Pharmacology; Shen Zhang, Ph.D. and Jason X-J Yuan, M.D., Ph.D., UCSD Department of Medicine, and Patricia A. Thistlethwaite, M.D., Ph.D., UCSD Department of Surgery. The study was funded by the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of California, San Diego. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Diego. "Medical Researchers Say Statins, Other Cholesterol-Depleting Agents Affect Hypertension." ScienceDaily. ScienceDaily, 12 April 2005. <www.sciencedaily.com/releases/2005/04/050411204830.htm>.
University Of California, San Diego. (2005, April 12). Medical Researchers Say Statins, Other Cholesterol-Depleting Agents Affect Hypertension. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2005/04/050411204830.htm
University Of California, San Diego. "Medical Researchers Say Statins, Other Cholesterol-Depleting Agents Affect Hypertension." ScienceDaily. www.sciencedaily.com/releases/2005/04/050411204830.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins